59 related articles for article (PubMed ID: 8523338)
1. Treatment of rheumatoid arthritis with platelet activating factor antagonist BN 50730.
Hilliquin P; Guinot P; Chermat-Izard V; Puechal X; Menkes CJ
J Rheumatol; 1995 Sep; 22(9):1651-4. PubMed ID: 8523338
[TBL] [Abstract][Full Text] [Related]
2. A double blind, placebo controlled study of a platelet activating factor antagonist in patients with rheumatoid arthritis.
Hilliquin P; Chermat-Izard V; Menkes CJ
J Rheumatol; 1998 Aug; 25(8):1502-7. PubMed ID: 9712091
[TBL] [Abstract][Full Text] [Related]
3. A platelet activating factor receptor antagonist prevents the development of chronic arthritis in mice.
Palacios I; Miguélez R; Sánchez-Pernaute O; Gutierrez S; Egido J; Herrero-Beaumont G
J Rheumatol; 1999 May; 26(5):1080-6. PubMed ID: 10332972
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.
Simon LS; Lanza FL; Lipsky PE; Hubbard RC; Talwalker S; Schwartz BD; Isakson PC; Geis GS
Arthritis Rheum; 1998 Sep; 41(9):1591-602. PubMed ID: 9751091
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits.
Yue TL; Farhat M; Rabinovici R; Perera PY; Vogel SN; Feuerstein G
J Pharmacol Exp Ther; 1990 Sep; 254(3):976-81. PubMed ID: 2395125
[TBL] [Abstract][Full Text] [Related]
6. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
Karasawa A; Rochester JA; Lefer AM
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.
Yue TL; Rabinovici R; Farhat M; Feuerstein G
J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837
[TBL] [Abstract][Full Text] [Related]
8. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
Ernestam S; Hafström I; Werner S; Carlström K; Tengstrand B
J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis.
Miguélez R; Palacios I; Navarro F; Gutierrez S; Sanchez-Pernaute O; Egido J; González E; Herrero-Beaumont G
J Lipid Mediat Cell Signal; 1996 Jan; 13(1):35-49. PubMed ID: 8821809
[TBL] [Abstract][Full Text] [Related]
10. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.
Kuuliala A; Nissinen R; Kautiainen H; Repo H; Leirisalo-Repo M
Ann Rheum Dis; 2006 Jan; 65(1):26-9. PubMed ID: 15941839
[TBL] [Abstract][Full Text] [Related]
11. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
[TBL] [Abstract][Full Text] [Related]
12. Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730.
Hilliquin P; Natour J; Aissa J; Guinot P; Laoussadi S; Benveniste J; Menkes CJ; Arnoux B
Ann Rheum Dis; 1995 Feb; 54(2):140-3. PubMed ID: 7702404
[TBL] [Abstract][Full Text] [Related]
13. Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial.
Le Loët X; Nordström D; Rodriguez M; Rubbert A; Sarzi-Puttini P; Wouters JM; Woolley JM; Wright N; Lawrence C; Appleton B
J Rheumatol; 2008 Aug; 35(8):1538-44. PubMed ID: 18634163
[TBL] [Abstract][Full Text] [Related]
14. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
[TBL] [Abstract][Full Text] [Related]
15. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
Dyson MC; Bellan JA; Minkes RK; Beckerman RC; Wegmann MJ; Braquet P; McNamara DB; Kadowitz PJ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1320-7. PubMed ID: 2175802
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].
Wallenius M; Rødevand E; Skomsvoll JF
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1664-6. PubMed ID: 15976836
[TBL] [Abstract][Full Text] [Related]
17. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
[TBL] [Abstract][Full Text] [Related]
18. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M
J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385
[TBL] [Abstract][Full Text] [Related]
19. Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.
Wegrzyn J; Adeleine P; Miossec P
Ann Rheum Dis; 2004 Oct; 63(10):1232-4. PubMed ID: 15361377
[TBL] [Abstract][Full Text] [Related]
20. Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.
Silverman MH; Strand V; Markovits D; Nahir M; Reitblat T; Molad Y; Rosner I; Rozenbaum M; Mader R; Adawi M; Caspi D; Tishler M; Langevitz P; Rubinow A; Friedman J; Green L; Tanay A; Ochaion A; Cohen S; Kerns WD; Cohn I; Fishman-Furman S; Farbstein M; Yehuda SB; Fishman P
J Rheumatol; 2008 Jan; 35(1):41-8. PubMed ID: 18050382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
